| Literature DB >> 35720182 |
Xuwen Li1,2, Sumaira Naseem3, Riaz Hussain4, Abdul Ghaffar3, Kun Li1,2, Ahrar Khan5,6.
Abstract
Pyriproxyfen (PPF) mimics a natural hormone in insects and disrupts their growth. It is a well-known synthetic insecticide and aromatic juvenile hormone analog frequently used in agriculture and vegetable crops to control various insect species. At present, scanty information is available about the possible potential threats of PPF in aquatic organisms. Therefore, in this study, different toxico-pathologic endpoints of PPF like DNA damage, biomarkers of oxidative stress, and status of antioxidant enzymes were determined in Labeo rohita (freshwater fish). In our study, 60 active, free from any external obvious ailments, same size, age, and body mass were randomly allocated to four glass aquaria (T0-T3) separately containing 100 L water. The fish present in groups T1, T2, and T3 were administered PPF dissolved in water 300, 600, and 900 μg/L for 30 days. Different tissues including the blood and visceral organs were obtained from each fish on days 10, 20, and 30 of the experiment. Results on various morphological and nuclear changes in red blood cells of PPF-exposed Labeo rohita fish including pear-shaped erythrocytes, spherocytes, red blood cells with a blebbed nucleus, micronucleus, and nuclear remnants were significantly increased. Our results on genotoxicity (comet assay) recorded significantly (P ≤ 0.05) increased DNA damage in various tissues of insecticide-exposed fish. The results on oxidative stress profile (reactive oxygen species and thiobarbituric acid reactive substances) and antioxidant enzymes (reduced glutathione superoxide dismutase, peroxidase, and catalase) in multiple tissues of Labeo rohita fish concluded significantly (P ≤ 0.05) higher quantity of biomarkers of oxidative stress and lower concentrations of different antioxidant enzymes in treated fish. Hence, the findings of our experimental research determine that PPF could induce adverse toxic impacts on multiple tissues of Labeo rohita fish.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35720182 PMCID: PMC9205694 DOI: 10.1155/2022/5859266
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 7.310
Various morphological and nuclear alterations in erythrocytes of Labeo rohita fish exposed to different pyriproxyfen concentrations.
| Parameters/days | Groups/treatment | |||
|---|---|---|---|---|
| T0 (0.0) | T1 (300 | T2 (600 | T3 (900 | |
| Erythrocytes with lobed nucleus (%) | ||||
| 10 | 1.39 ± 0.08 | 1.42 ± 0.06 | 1.57 ± 0.09 | 3.43 ± 0.18∗ |
| 20 | 1.40 ± 0.02 | 1.43 ± 0.04 | 1.59 ± 0.08 | 3.45 ± 0.23∗ |
| 30 | 1.41 ± 0.03 | 1.47 ± 0.04 | 3.61 ± 0.09∗ | 4.46 ± 0.18∗ |
| Erythrocytes with blabbed nucleus (%) | ||||
| 10 | 1.22 ± 0.17 | 1.39 ± 0.22 | 1.54 ± 0.13 | 2.99 ± 0.12∗ |
| 20 | 1.24 ± 0.15 | 1.48 ± 0.17 | 1.57 ± 0.11 | 3.18 ± 0.09∗ |
| 30 | 1.29 ± 0.14 | 1.49 ± 0.16 | 2.64 ± 0.15∗ | 3.19 ± 0.07∗ |
| Erythrocytes with vacuolated nucleus (%) | ||||
| 10 | 2.36 ± 0.04 | 2.43 ± 0.02 | 2.63 ± 0.12 | 2.99 ± 0.06∗ |
| 20 | 2.38 ± 0.02 | 2.44 ± 0.04 | 2.65 ± 0.05 | 3.03 ± 0.09∗ |
| 30 | 2.40 ± 0.03 | 2.47 ± 0.04 | 3.69 ± 0.06∗ | 3.90 ± 0.16∗ |
| Notched nucleus (%) | ||||
| 10 | 1.79 ± 0.01 | 1.86 ± 0.03 | 2.92 ± 0.08 | 2.66 ± 0.10∗ |
| 20 | 1.80 ± 0.02 | 1.89 ± 0.02 | 1.95 ± 0.09 | 2.70 ± 0.07∗ |
| 30 | 1.81 ± 0.01 | 1.90 ± 0.03 | 2.67 ± 0.12∗ | 2.81 ± 0.09∗ |
| Binucleate nucleus (%) | ||||
| 10 | 1.44 ± 0.18 | 1.50 ± 0.13 | 1.64 ± 0.09 | 1.77 ± 0.05 |
| 20 | 1.48 ± 0.18 | 1.55 ± 0.05 | 1.71 ± 0.09 | 2.89 ± 0.09∗ |
| 30 | 1.49 ± 0.13 | 1.63 ± 0.07 | 3.88 ± 0.05∗ | 3.91 ± 0.08∗ |
| Pear shaped (%) | ||||
| 10 | 3.87 ± 0.34 | 4.04 ± 0.18 | 4.10 ± 0.14 | 7.07 ± 0.04∗ |
| 20 | 3.89 ± 0.31 | 4.19 ± 0.16 | 6.68 ± 0.32∗ | 7.16 ± 0.19∗ |
| 30 | 3.66 ± 0.21 | 4.20 ± 0.43 | 6.75 ± 0.28∗ | 7.19 ± 0.08∗ |
| Micronucleus (%) | ||||
| 10 | 1.73 ± 0.18 | 1.83 ± 0.19 | 2.24 ± 0.08∗ | 3.92 ± 0.08∗ |
| 20 | 1.74 ± 0.24 | 1.96 ± 0.09 | 2.58 ± 0.13∗ | 4.04 ± 0.05∗ |
| 30 | 1.75 ± 0.21 | 2.10 ± 0.13 | 3.13 ± 0.14∗ | 4.26 ± 0.06∗ |
| Condensed nucleus (%) | ||||
| 10 | 2.11 ± 0.57 | 2.24 ± 0.21 | 2.53 ± 0.66 | 3.41 ± 0.12∗ |
| 20 | 2.30 ± 0.33 | 2.35 ± 0.51 | 3.82 ± 0.16∗ | 4.30 ± 0.05∗ |
| 30 | 2.45 ± 0.48 | 2.47 ± 0.13 | 4.95 ± 0.69∗ | 6.25 ± 0.26∗ |
| Spindle shaped erythrocyte (%) | ||||
| 10 | 1.83 ± 0.21 | 2.09 ± 0.15 | 3.22 ± 0.19∗ | 4.40 ± 0.26∗ |
| 20 | 1.95 ± 0.19 | 2.16 ± 0.19 | 3.35 ± 0.14∗ | 4.88 ± 0.21∗ |
| 30 | 1.84 ± 0.34 | 2.23 ± 0.33 | 3.49 ± 0.17∗ | 5.12 ± 0.09∗ |
| Spherocytes (%) | ||||
| 10 | 1.94 ± 0.03 | 2.18 ± 0.17 | 3.46 ± 0.08∗ | 4.20 ± 0.23∗ |
| 20 | 1.98 ± 0.08 | 2.21 ± 0.15 | 3.56 ± 0.09∗ | 4.45 ± 0.16∗ |
| 30 | 2.01 ± 0.03 | 2.25 ± 0.09 | 3.78 ± 0.16∗ | 4.69 ± 0.31∗ |
In each row, values (Mean ± SE) bearing asterisks differ significantly (P ≤ 0.05) from that of values in untreated (T0 negative control) fish. T1, T2, and T3 are positive control and dose based.
Figure 1Blood smear of Labeo rohita treated with pyriproxyfen (T3: 900 μg/L at 30 days experiment). Upper and lower figures showing (1) bi-nucleus/dividing nucleus, (2) micronucleus, (3) condensed nuclei, (4) notched nuclei, (5) pear-shaped erythrocyte, and (6) macrocyte (immature erythrocytes). Stain: Giemsa. 1000×.
Figure 2Blood smear of Labeo rohita treated with pyriproxyfen (T3: 900 μg/L at 30-day experiment). Upper and lower figures showing (1) notched nucleus, (2) macrocyte (immature erythrocytes), (3) pear-shaped erythrocyte, (4) abnormal erythrocytes, (5) spindle-shaped erythrocyte, (6) elliptical erythrocyte, (7) condensed nuclei, (8) macrocyte, (9) micronucleus, (10) microcyte, and (11) bi-nucleus/dividing nucleus. Stain: Giemsa. 1000×.
Oxidative stress indices and antioxidant enzyme levels in liver tissues of Labeo rohita exposed to pyriproxyfen.
| Parameters/days | Groups/treatment | |||
|---|---|---|---|---|
| T0 (0.0) | T1 (300 | T2 (600 | T3 (900 | |
| ROS (optical density) | ||||
| 10 | 0.36 ± 0.03 | 0.37 ± 0.02 | 0.40 ± 0.03 | 0.84 ± 0.07∗ |
| 20 | 0.37 ± 0.01 | 0.39 ± 0.01 | 0.67 ± 0.02∗ | 0.86 ± 0.05∗ |
| 30 | 0.39 ± 0.04 | 0.42 ± 0.03 | 0.75 ± 0.02∗ | 0.92 ± 0.05∗ |
| TBARS (nmol/TBARS formed/mg protein/min) | ||||
| 10 | 37.42 ± 2.93 | 39.23 ± 1.95 | 41.07 ± 1.15 | 54.93 ± 2.74∗ |
| 20 | 38.89 ± 1.94 | 40.68 ± 2.95 | 50.44 ± 1.97∗ | 56.25 ± 3.92∗ |
| 30 | 40.02 ± 3.94 | 41.95 ± 2.93 | 51.88 ± 2.34∗ | 58.83 ± 4.53∗ |
| Reduced GSH ( | ||||
| 10 | 8.66 ± 1.17 | 7.65 ± 0.06 | 6.64 ± 0.13 | 5.64 ± 0.15∗ |
| 20 | 8.38 ± 1.12 | 7.44 ± 1.10 | 6.05 ± 0.02 | 5.56 ± 0.12∗ |
| 30 | 8.35 ± 1.14 | 7.38 ± 1.05 | 5.93 ± 1.15∗ | 5.48 ± 0.14∗ |
|
| ||||
| SOD (units/mg protein) | ||||
| 10 | 11.65 ± 0.12 | 10.97 ± 0.12 | 10.29 ± 0.13 | 10.27 ± 0.11 |
| 20 | 11.64 ± 0.15 | 10.32 ± 0.15 | 9.46 ± 0.15 | 7.58 ± 0.14∗ |
| 30 | 10.75 ± 0.18 | 9.68 ± 0.18 | 7.10 ± 0.18∗ | 7.04 ± 0.17∗ |
| CAT (units/min) | ||||
| 10 | 8.70 ± 0.19 | 7.52 ± 0.19 | 7.14 ± 0.19 | 5.16 ± 0.19∗ |
| 20 | 7.99 ± 0.17 | 7.35 ± 0.16 | 5.63 ± 0.16∗ | 5.03 ± 0.16∗ |
| 30 | 7.95 ± 0.16 | 7.02 ± 0.16 | 5.46 ± 0.16∗ | 4.95 ± 0.16∗ |
| POD (units/ | ||||
| 10 | 4.08 ± 0.09 | 3.56 ± 0.09 | 2.78 ± 0.09∗ | 2.47 ± 0.08∗ |
| 20 | 4.03 ± 0.08 | 3.47 ± 0.08 | 2.63 ± 0.08∗ | 2.41 ± 0.08∗ |
| 30 | 3.96 ± 0.08 | 3.39 ± 0.08 | 2.55 ± 0.08∗ | 2.38 ± 0.08∗ |
In each row, values (Mean ± SE) bearing asterisks differ significantly (P ≤ 0.05) from that of values in untreated (T0 negative control) fish. T1, T2, and T3 are positive control and dose based.
Oxidative stress parameters and antioxidant enzyme levels in Labeo rohita kidneys tissues subjected to pyriproxyfen dosages.
| Parameters/days | Groups/treatment | |||
|---|---|---|---|---|
| T0 (0.0) | T1 (300 | T2 (600 | T3 (900 | |
| ROS (optical density) | ||||
| 10 | 0.56 ± 0.03 | 0.57 ± 0.01 | 0.63 ± 0.01 | 0.71 ± 0.02∗ |
| 20 | 0.53 ± 0.01 | 0.59 ± 0.02 | 0.65 ± 0.07∗ | 0.74 ± 0.03∗ |
| 30 | 0.57 ± 0.01 | 0.62 ± 0.02 | 0.70 ± 0.05∗ | 0.78 ± 0.07∗ |
| TBARS (nmol/TBARS formed/mg protein/min) | ||||
| 10 | 28.51 ± 1.51 | 30.21 ± 1.11 | 35.92 ± 0.5∗ | 39.63 ± 1.39∗ |
| 20 | 29.08 ± 1.63 | 31.08 ± 1.16 | 37.07 ± 0.6∗ | 41.06 ± 1.83∗ |
| 30 | 29.72 ± 1.71 | 33.79 ± 1.17 | 37.79 ± 0.7∗ | 41.83 ± 1.77∗ |
| Reduced GSH ( | ||||
| 10 | 7.70 ± 0.3 | 6.45 ± 0.3 | 5.21 ± 0.2∗ | 3.95 ± 0.2∗ |
| 20 | 7.66 ± 0.3 | 6.35 ± 0.2 | 5.18 ± 0.2∗ | 3.82 ± 0.2∗ |
| 30 | 7.54 ± 0.3 | 6.31 ± 0.2 | 5.10 ± 0.2∗ | 3.79 ± 0.2∗ |
|
| ||||
| SOD (units/mg protein) | ||||
| 10 | 15.51 ± 0.36 | 13.53 ± 0.35 | 11.56 ± 0.33∗ | 9.55 ± 0.32∗ |
| 20 | 15.40 ± 0.36 | 13.14 ± 0.35 | 10.99 ± 0.33∗ | 8.77 ± 0.32∗ |
| 30 | 15.26 ± 0.36 | 13.10 ± 0.35 | 10.86 ± 0.33∗ | 8.68 ± 0.32∗ |
| CAT (units/min) | ||||
| 10 | 5.12 ± 0.1 | 4.58 ± 0.09 | 3.84 ± 0.09∗ | 3.46 ± 0.07∗ |
| 20 | 5.08 ± 0.1 | 4.56 ± 0.09 | 3.78 ± 0.08∗ | 3.43 ± 0.07∗ |
| 30 | 5.04 ± 0.1 | 4.45 ± 0.09 | 3.62 ± 0.08∗ | 3.30 ± 0.06∗ |
| POD (units/ | ||||
| 10 | 5.98 ± 0.13 | 5.33 ± 0.13 | 4.17 ± 0.11∗ | 4.04 ± 0.10∗ |
| 20 | 5.92 ± 0.13 | 5.30 ± 0.12 | 4.13 ± 0.11∗ | 3.95 ± 0.10∗ |
| 30 | 5.89 ± 0.13 | 5.27 ± 0.12 | 4.03 ± 0.10∗ | 3.89 ± 0.10∗ |
In each row, values (Mean ± SE) bearing asterisks differ significantly (P ≤ 0.05) from that of values in untreated (T0 negative control) fish. T1, T2, and T3 are positive control and dose based.
Oxidative stress parameters and antioxidant enzyme levels in Labeo rohita gills tissues subjected to pyriproxyfen dosages.
| Parameters/days | Groups/treatment | |||
|---|---|---|---|---|
| T0 (0.0) | T1 (300 | T2 (600 | T3 (900 | |
| ROS (optical density) | ||||
| 10 | 0.34 ± 0.03 | 0.37 ± 0.01 | 0.49 ± 0.07∗ | 0.55 ± 0.09∗ |
| 20 | 0.35 ± 0.05 | 0.39 ± 0.04 | 0.53 ± 0.06∗ | 0.57 ± 0.07∗ |
| 30 | 0.37 ± 0.04 | 0.41 ± 0.01 | 0.56 ± 0.08∗ | 0.59 ± 0.09∗ |
| TBARS (nmol/TBARS formed/mg protein/min) | ||||
| 10 | 40.67 ± 1.63 | 44.47 ± 2.12 | 58.27 ± 2.22∗ | 61.07 ± 2.33∗ |
| 20 | 41.13 ± 2.61 | 44.88 ± 2.31 | 58.64 ± 3.41∗ | 62.39 ± 2.29∗ |
| 30 | 41.20 ± 1.61 | 45.04 ± 1.36 | 61.82 ± 2.39∗ | 63.70 ± 2.27∗ |
| Reduced GSH ( | ||||
| 10 | 2.58 ± 0.05 | 2.24 ± 0.10 | 1.90 ± 0.04∗ | 1.56 ± 0.16∗ |
| 20 | 2.44 ± 0.11 | 2.23 ± 0.14 | 1.83 ± 0.03∗ | 1.52 ± 0.17∗ |
| 30 | 2.34 ± 0.15 | 2.05 ± 0.17 | 1.76 ± 0.08∗ | 1.47 ± 0.25∗ |
|
| ||||
| SOD (units/mg protein) | ||||
| 10 | 10.79 ± 1.2 | 9.73 ± 1.12 | 8.98 ± 0.04 | 7.24 ± 0.12∗ |
| 20 | 10.68 ± 1.1 | 9.53 ± 1.17 | 8.13 ± 0.21∗ | 7.22 ± 0.18∗ |
| 30 | 10.57 ± 1.4 | 9.32 ± 1.11 | 8.07 ± 0.13∗ | 6.83 ± 0.31∗ |
| CAT (units/min) | ||||
| 10 | 3.03 ± 0.14 | 2.89 ± 0.12 | 2.48 ± 0.08 | 2.19 ± 0.13∗ |
| 20 | 2.98 ± 0.11 | 2.79 ± 0.17 | 2.33 ± 0.08∗ | 2.15 ± 0.19∗ |
| 30 | 2.95 ± 0.09 | 2.73 ± 0.15 | 2.19 ± 0.14∗ | 2.08 ± 0.21∗ |
| POD (units/ | ||||
| 10 | 0.41 ± 0.05 | 0.37 ± 0.01 | 0.36 ± 0.01 | 0.26 ± 0.03∗ |
| 20 | 0.40 ± 0.04 | 0.36 ± 0.02 | 0.30 ± 0.05∗ | 0.24 ± 0.04∗ |
| 30 | 0.39 ± 0.05 | 0.34 ± 0.04 | 0.29 ± 0.06∗ | 0.22 ± 0.02∗ |
In each row, values (Mean ± SE) bearing asterisks differ significantly (P ≤ 0.05) from that of values in untreated (T0 negative control) fish. T1, T2, and T3 are positive control and dose based.
Oxidative stress parameters and antioxidant enzyme levels in Labeo rohita brain tissue subjected to pyriproxyfen dosages.
| Parameters/days | Groups/treatments | |||
|---|---|---|---|---|
| T0 (0.0) | T1 (300 | T2 (600 | T3 (900 | |
| ROS (optical density) | ||||
| 10 | 0.48 ± 0.02 | 0.50 ± 0.02 | 0.51 ± 0.03 | 0.53 ± 0.03 |
| 20 | 0.46 ± 0.02 | 0.52 ± 0.02 | 0.59 ± 0.03∗ | 0.72 ± 0.04∗ |
| 30 | 0.51 ± 0.02 | 0.53 ± 0.03 | 0.66 ± 0.03∗ | 0.76 ± 0.04∗ |
| TBARS (nmol/TBARS formed/mg protein/min) | ||||
| 10 | 18.60 ± 2.11 | 19.29 ± 1.03 | 20.97 ± 1.12 | 21.66 ± 1.06 |
| 20 | 19.08 ± 2.01 | 20.77 ± 1.21 | 26.46 ± 1.13∗ | 30.14 ± 1.13∗ |
| 30 | 19.18 ± 2.04 | 22.92 ± 1.5 | 26.66 ± 1.17∗ | 30.40 ± 2.13∗ |
| Reduced GSH ( | ||||
| 10 | 3.01 ± 0.06 | 2.96 ± 0.06 | 2.79 ± 0.05 | 2.89 ± 0.04 |
| 20 | 2.96 ± 0.06 | 2.77 ± 0.05 | 2.66 ± 0.04 | 1.77 ± 0.03∗ |
| 30 | 2.88 ± 0.06 | 2.75 ± 0.05 | 2.10 ± 0.04∗ | 1.73 ± 0.03∗ |
|
| ||||
| SOD (units/mg protein) | ||||
| 10 | 13.65 ± 0.3 | 12.09 ± 0.3 | 12.02 ± 0.2 | 11.96 ± 0.2 |
| 20 | 13.56 ± 0.3 | 12.20 ± 0.2 | 11.73 ± 0.2 | 8.87 ± 0.1∗ |
| 30 | 13.45 ± 0.3 | 11.88 ± 0.2 | 10.32 ± 0.2∗ | 8.75 ± 0.1∗ |
| CAT (units/min) | ||||
| 10 | 4.16 ± 0.08 | 3.93 ± 0.08 | 3.85 ± 0.07 | 3.76 ± 0.06 |
| 20 | 4.12 ± 0.08 | 3.68 ± 0.08 | 3.77 ± 0.07 | 2.46 ± 0.06∗ |
| 30 | 4.07 ± 0.08 | 3.59 ± 0.07 | 2.98 ± 0.07∗ | 2.23 ± 0.06∗ |
| POD (units/ | ||||
| 10 | 3.04 ± 0.06 | 2.79 ± 0.06 | 2.64 ± 0.05 | 2.59 ± 0.04 |
| 20 | 3.01 ± 0.06 | 2.73 ± 0.05 | 2.35 ± 0.05 | 1.98 ± 0.04∗ |
| 30 | 3.03 ± 0.06 | 2.69 ± 0.05 | 2.03 ± 0.05∗ | 1.94 ± 0.04∗ |
In each row, values (Mean ± SE) bearing asterisks differ significantly (P ≤ 0.05) from that of values in untreated (T0 negative control) fish. T1, T2, and T3 are positive control and dose based.
Figure 3Comet assay showing DNA damage in isolated cells of the liver of fish treated with pyriproxyfen. (a) 600 μg/L (T2) and (b) 900 μg/L (T3) at 30-day experiment. Note the frequency and intensity is increasing with the dose of pyriproxyfen increasing.
DNA damage in different visceral organs of Labeo rohita (as observed by Comet assay) treated with various doses of pyriproxyfen.
| Parameters/days | Groups/treatment | |||
|---|---|---|---|---|
| T0 (0.0) | T1 (300 | T2 (600 | T3 (900 | |
| DNA damage by comet assay in liver | ||||
| 10 | 2.35 ± 0.04 | 2.37 ± 0.05 | 2.39 ± 0.03 | 3.42 ± 0.14∗ |
| 20 | 2.37 ± 0.09 | 2.42 ± 0.06 | 3.47 ± 0.02∗ | 4.52 ± 0.19∗ |
| 30 | 2.43 ± 0.02 | 2.56 ± 0.02 | 4.70 ± 0.01∗ | 4.84 ± 0.22∗ |
| DNA damage by comet assay in kidneys | ||||
| 10 | 2.55 ± 0.19 | 2.67 ± 0.17 | 2.69 ± 0.27 | 4.47 ± 0.45∗ |
| 20 | 2.57 ± 0.21 | 2.72 ± 0.16 | 4.87 ± 0.51∗ | 5.53 ± 0.49∗ |
| 30 | 2.63 ± 0.25 | 2.76 ± 0.21 | 5.70 ± 0.61∗ | 5.81 ± 0.28∗ |
| DNA damage by comet assay in gills | ||||
| 10 | 2.23 ± 0.23 | 2.41 ± 0.11 | 2.51 ± 0.21 | 3.94 ± 0.44∗ |
| 20 | 2.31 ± 0.31 | 2.44 ± 0.14 | 3.87 ± 0.02∗ | 4.55 ± 0.39∗ |
| 30 | 2.23 ± 0.26 | 2.46 ± 0.12 | 4.77 ± 0.01∗ | 5.89 ± 0.42∗ |
In each row, values (Mean ± SE) bearing asterisks differ significantly (P ≤ 0.05) from that of values in untreated (T0 negative control) fish. T1, T2, and T3 are positive control and dose based.